Pharma’s Ghost Labs Find New Life

Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.

Written byKatarina Zimmer
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

ABOVE: MODIFIED FROM © ISTOCK.com, 3ddi3

T

he hallways of Pfizer’s first-ever facility once swarmed with more than 1,000 workers tasked with making some of the most popular drugs of our time, including the erectile dysfunction treatment Viagra and the antibiotic Zithromax. Nowadays, the building in Brooklyn, New York, carries scents of chocolate, baked goods, beer, and a lingering waft of construction.

Pfizer began to wind down its production of drugs here decades ago, and the last of the company’s Brooklyn employees had to leave in 2008 when the pharmaceutical giant closed down the site as part of a wave of modernizing changes. But Pfizer’s birthplace has since become a much sought-after space in one of Brooklyn’s most cramped neighborhoods, with about 1,600 people now working in the building.

The eighth floor, which used to be reserved for the offices of Pfizer’s chief executives, now hosts counterterrorism training run by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile

Published In

November 2019

Oceanic Connections

Biologists consider the movements of marine animals

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery